NCT05275868 - Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer | Biotech Hunter

Enrollment

140

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

July 28, 2027

Study Completion Date

July 28, 2027

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

MGY825

investigational drug

Trial Locations (16)

9007

RECRUITING

Novartis Investigative Site, Sankt Gallen

10015

RECRUITING

NYU School of Medicine, New York

10017

RECRUITING

Memorial Sloan Kettering Onc. Dept, New York

RECRUITING

Memorial Sloan Kettering, New York

28050

RECRUITING

Novartis Investigative Site, Madrid

45147

RECRUITING

Novartis Investigative Site, Essen

50937

COMPLETED

Novartis Investigative Site, Cologne

60590

RECRUITING

Novartis Investigative Site, Frankfurt am Main

63110

ACTIVE_NOT_RECRUITING

Wash U School of Medicine, St Louis

77030

RECRUITING

Uni Of TX MD Anderson Cancer Cntr, Houston

02114

RECRUITING

Massachusetts General Hospital, Boston

02115

RECRUITING

Dana Farber Cancer Institute, Boston

104 0045

RECRUITING

Novartis Investigative Site, Chuo Ku

03080

RECRUITING

Novartis Investigative Site, Seoul

08035

RECRUITING

Novartis Investigative Site, Barcelona

CH 1211

RECRUITING

Novartis Investigative Site, Geneva